AKA. N. Krylova

A. N. Krylova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


A. N. Krylova has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Approaches to the diagnosis of immunodeficiency disorders in children with Down syndrome

    by A. Yu. Chirkova, E. G. Novopoltseva, A. A. Tarasova, K. Yu. Ozhgikhin, A. S. Veselova, I. D. Morozov, U. A. Klokova, H. F. Aksyanova, N. Yu. Smelikova, E. Yu. Baskakova, et al.

       Relevance. Down syndrome is one of the most common genetic diseases worldwide. People with this syndrome are at risk for developing immunodeficiency conditions. The article discusses the results of a study of TREC and KREC concentrations in children with Down syndrome.  The aim of the study was to determine the concentration of TREC and KREC in children with Down syndrome compared with healthy children.   Materials and methods. A prospective study was conducted to determine the content of TREC and KREC in the bloo d of children and adolescents with Down syndrome.   Results. It was found that the co ncentration of TREС in children with Down syn drome is significantly lower than in healthy children of the appropriate age, which indicates a violation in the development of the T-cell link of immunity. A similar pattern is observed for KREС levels, which indicates a violation of the maturation of B-lymphocytes responsible for the synthesis of antibodies.   Conclusion. This study highlights the importance of early diagnosis and monitoring of the immune status in children with Down syndrome by determining the conc entration of TREС and KREС, which will allow timely corrective measures and prevent the development of complications.


  • Patients after acute decompensation of Heart Failure: adherence to self-monitoring and treatment depending on the mode of outpatient monitoring

    by N. G. Vinogradova, A. A. Tjurin, I. V. Fomin, D. S. Polyakov, E. Yu. Ivanchenko, A. R. Vaisberg, E. V. Shcherbinina, A. N. Krylova

    Aim To evaluate compliance with self-monitoring and drug and non-drug treatment of patients after ADHF during the management at a specialized center for CHF treatment (CCHF) or in real-life clinical practice. Material and methods The study included 942 CHF patients after ADHF. In two years, the entire sample of patients was retrospectively divided into 4 groups based on their compliance with the management at the CCHF: group 1, 313 patients who were managed at the CCHF continuously for two years; group 2, 383 patients who choose the management at district outpatient clinics after discharge from a hospital; group 3, 197 patients who visited the CCHF for one year but then stopped the management; and group 4, 49 patients who initially preferred the management at district clinics but then switched to constant management at the CCHF. Compliance with recommendations was analyzed by data of outpatient clinical records or by data of structured telephone calls for patients who did not visit the CCHF or did not follow the visit schedule. Statistics was performed with a Statistica 7.0 for Windows software package. Results Patients of groups 2 (72.4 %) and 3 (88.3 %) performed self-monitoring less frequently whereas patients of groups 1 (94.6 %) and 4 (87.8 %) performed self-monitoring more frequently (р 1 / 3 =0.01, р 1 / 2 1 / 4 =0.07, р 2 / 4 =0.02, р 2 / 3 4 / 3 =0.9). Patients of group 2 (58.1 %) performed self-monitoring of heart rate less frequently than patients of groups 1, 3, and 4 (90.7 %, 81.7 %, and 87.8 %; р 1 / 3 =0.003, р 1 / 2 1 / 4 =0.5, р 2 / 4 2 / 3 4 / 3 =0.3). Patients of group 2 performed body weight self-monitoring less frequently than patients of groups 1, 3, and 4 (78.6 %, 67.9 %, and 72.9 %; р 1 / 3 =0.008, р 1 / 2 1 / 4 =0.4, р 2 / 4 =0.002, р 2 / 3 4 / 3 =0.5). Compliance with the diet and restriction of salt consumption was 32.3 % and 37.5 % in groups 1 and 4, and 24.9 % and 19.9 % in groups 2 and 3 (р 1 / 3 =0.002, р 1 / 2 =0.03, р 1 / 4 =0.5, р 2 / 4 =0.02, р 2 / 3 =0.2, and р 4 / 3 =0.009). Compliance with recommendations on physical rehabilitation was 44.7% in group 1, which was better than in groups 2, 3, and 4 (8.2 %, 21.6 %, and 9.1 %; р 1 / 2 1 / 3 =0.0003, р 1 / 4 =0.002, р 2 / 4 =0.9, р 2 / 3 =0.0006, and р 4 / 3 =0.2). At the end of the second year of follow-up, the actual proportion of patients taking ACE inhibitors/angiotensin receptor antagonists was low in groups 2, 3, and 4 (43.2 %, 45 %, and 66.7 %) and satisfactory in group 1 (92.4 %; р 1 / 2 1 / 3 1 / 4 2 / 3 =0.6, р 2 / 4 =0.05, and р 3 / 4 =0.05). Proportion of patients taking beta-blockers was greater in group 1 (97.2 %) than in groups 2, 3. and 4 (73.2 %, 71.1 %, and 90.5 %; р 1 / 2 1 / 3 1 / 4 =00.08, р 2 / 3 =0.6, р 2 / 4 =0.1, and р 3 / 4 =0.06). Patients of group 1 (96.2 %) showed good compliance with the mineralocorticoid receptor antagonist treatment compared to groups 2, 3, and 4 (58.8 %, 55.4 %, and 81.2 %; р 1 / 2 1 / 3 1 / 4 2 / 3 =0.5, р 2 / 4 =0.1, and р 3 / 4 =0. Conclusion Only scheduled management by a cardiologist of the specialized CCHF provided sufficient compliance with self-monitoring and drug and non-drug treatment of CHF during the long-term follow-up.